- Home
- RNAC vs FRPH Comparison
RNAC vs FRPH Comparison
Compare RNAC & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNAC | FRPH |
|---|---|---|
| Founded | 2007 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 238.9M | 420.6M |
| IPO Year | 2016 | 1995 |
Fundamental Metrics
Financial Performance| Metric | RNAC | FRPH |
|---|---|---|
| Price | $9.09 | $22.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $34.00 | N/A |
| AVG Volume (30 Days) | ★ 101.9K | 86.3K |
| Earning Date | 05-11-2026 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,797,000.00 | ★ $42,846,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.57 |
| 52 Week Low | $5.60 | $20.53 |
| 52 Week High | $11.00 | $25.74 |
Technical Indicators
Market Signals| Indicator | RNAC | FRPH |
|---|---|---|
| Relative Strength Index (RSI) | 48.36 | 48.55 |
| Support Level | $8.80 | $21.87 |
| Resistance Level | $9.27 | $23.19 |
| Average True Range (ATR) | 0.69 | 0.50 |
| MACD | -0.12 | 0.08 |
| Stochastic Oscillator | 17.14 | 45.08 |
Price Performance
Historical ComparisonAbout RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, industrial, and office (the Development Segment), and (iv) management of mixed-use residential/retail properties owned through joint ventures.